<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>10</volume><submitter>Zheng Y</submitter><pubmed_abstract>&lt;b>Background:&lt;/b> Capillary malformation-arteriovenous malformation (CM-AVM) is an autosomal dominant disorder characterized by CMs, often in association with fast-flow vascular malformations. Alagille syndrome is an autosomal dominant multisystem disorder, usually involving hepatic, cardiac, ophthalmic, skeletal, or renal dysplasia. The combination of CM-AVM and Alagille syndrome in a patient presenting serious vascular malformations in the liver and heart has never been reported. Here, we report the case of a 20-month-old infant presenting these two diseases. &lt;b>Case presentation:&lt;/b> The patient manifested port-wine stains, congenital heart disease, cholestasis with abnormal morphology, and vascular anomalies. Color Doppler (B-mode) ultrasonography, and radiological imaging including computed tomography (CT) with enhanced three-dimensional (3D) reconstruction and angiography, revealed a type II Abernethy malformation in the hepatic portal vein. The left hepatic lobe was enlarged showing dilation of the portal vein and the left artery. Whole exome sequencing (WES) identified a paternally inherited &lt;i>RASA1&lt;/i> heterozygous pathogenic variant p.(Ser219Ter) causing CM-AVM and a &lt;i>de novo NOTCH2&lt;/i> heterozygous variant p.(Met2042Thr) associated with Alagille syndrome. &lt;b>Conclusion:&lt;/b> This is the first case of combined CM-AVM and Alagille syndrome presenting serious liver and heart abnormalities diagnosed using imaging technology and WES. The patient harbored variants in two genes: &lt;i>RASA1&lt;/i> and &lt;i>NOTCH2&lt;/i>, which rarely contribute to aberrant vascular development. This report highlights the value of accurately diagnosing similar diseases and guiding therapy using genetic testing combined with careful clinical examinations.</pubmed_abstract><journal>Frontiers in genetics</journal><pagination>1088</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6848451</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Capillary Malformation-Arteriovenous Malformation Combined Alagille Syndrome in a Patient With Double Gene Variations of &lt;i>RASA1&lt;/i> and &lt;i>NOTCH2&lt;/i>.</pubmed_title><pmcid>PMC6848451</pmcid><pubmed_authors>Peng Y</pubmed_authors><pubmed_authors>Zheng Y</pubmed_authors><pubmed_authors>Yin Q</pubmed_authors><pubmed_authors>Zhang S</pubmed_authors><pubmed_authors>Li L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Capillary Malformation-Arteriovenous Malformation Combined Alagille Syndrome in a Patient With Double Gene Variations of &lt;i>RASA1&lt;/i> and &lt;i>NOTCH2&lt;/i>.</name><description>&lt;b>Background:&lt;/b> Capillary malformation-arteriovenous malformation (CM-AVM) is an autosomal dominant disorder characterized by CMs, often in association with fast-flow vascular malformations. Alagille syndrome is an autosomal dominant multisystem disorder, usually involving hepatic, cardiac, ophthalmic, skeletal, or renal dysplasia. The combination of CM-AVM and Alagille syndrome in a patient presenting serious vascular malformations in the liver and heart has never been reported. Here, we report the case of a 20-month-old infant presenting these two diseases. &lt;b>Case presentation:&lt;/b> The patient manifested port-wine stains, congenital heart disease, cholestasis with abnormal morphology, and vascular anomalies. Color Doppler (B-mode) ultrasonography, and radiological imaging including computed tomography (CT) with enhanced three-dimensional (3D) reconstruction and angiography, revealed a type II Abernethy malformation in the hepatic portal vein. The left hepatic lobe was enlarged showing dilation of the portal vein and the left artery. Whole exome sequencing (WES) identified a paternally inherited &lt;i>RASA1&lt;/i> heterozygous pathogenic variant p.(Ser219Ter) causing CM-AVM and a &lt;i>de novo NOTCH2&lt;/i> heterozygous variant p.(Met2042Thr) associated with Alagille syndrome. &lt;b>Conclusion:&lt;/b> This is the first case of combined CM-AVM and Alagille syndrome presenting serious liver and heart abnormalities diagnosed using imaging technology and WES. The patient harbored variants in two genes: &lt;i>RASA1&lt;/i> and &lt;i>NOTCH2&lt;/i>, which rarely contribute to aberrant vascular development. This report highlights the value of accurately diagnosing similar diseases and guiding therapy using genetic testing combined with careful clinical examinations.</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019</publication><modification>2024-11-13T00:29:45.303Z</modification><creation>2020-05-21T20:10:12Z</creation></dates><accession>S-EPMC6848451</accession><cross_references><pubmed>31749841</pubmed><doi>10.3389/fgene.2019.01088</doi></cross_references></HashMap>